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Abstract
The aim of the present study was to evaluate renal and liver distribu-
tion of two monoclonal immunoglobulin light chains. The chains were
purified individually from the urine of patients with multiple myeloma
and characterized as lambda light chains with a molecular mass of 28
kDa. They were named BJg (high amount of galactose residues
exposed) and BJs (sialic acid residues exposed) on the basis of
carbohydrate content. A scintigraphic study was performed on male
Wistar rats weighing 250 g for 60 min after iv administration of 1 mg
of each protein (7.4 MBq), as the intact proteins and also after
carbohydrate oxidation. Images were obtained with a Siemens gamma
camera with a high-resolution collimator and processed with a
MicroDelta system. Hepatic and renal distribution were established
and are reported as percent of injected dose. Liver uptake of BJg was
significantly higher than liver uptake of BJs (94.3 vs 81.4%) (P<0.05).
This contributed to its greater removal from the intravascular compart-
ment, and consequently lower kidney accumulation of BJg in com-
parison to BJs (5.7 vs 18.6%) (P<0.05). After carbohydrate oxidation,
there was a decrease in hepatic accumulation of both proteins and
consequently a higher renal overload. The tissue distribution of
periodate-treated BJg was similar to that of native BJs: 82.7 vs 81.4%
in the liver and 17.3 vs 18.6% in the kidneys. These observations
indicate the important role of sugar residues of Bence Jones proteins
for their recognition by specific membrane receptors, which leads to
differential tissue accumulation and possible toxicity.
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Introduction
Multiple myeloma is a disease character-
ized by abnormal production of monoclonal
proteins, with a higher incidence in people
older than 50 years. Frequently, large a-
mounts of immunoglobulin light chains are
delivered to systemic circulation (1,2). Light
chains have a low molecular weight that
favors their excretion by glomerular filtra-
tion. Many factors contribute to the nephro-
toxic potential of these light chains, named
Bence Jones proteins (3): degree of poly-
merization, isotype, isoelectric point and gly-
cosylation. Clinical (4-8) and experimental
(9-12) studies have been conducted to eluci-
date the mechanisms of this toxicity. Bence
Jones proteins are highly glycosylated, dif-
fering from the pattern of normal secreted
immunoglobulins (13). The main organs re-
sponsible for their removal from the circula-
tion are the liver and kidney. In the liver,
and, to a lesser extent, in the kidneys, there is
a significant participation of the endocytic
apparatus composed of endocytic mem-
branes, vesicles, early endosomes, pre-lyso-
somes and lysosomes (14,15). In a review,
Bradbury and Bridges (16) focused on the
molecular mechanisms involved in regulat-
ing protein transport. Membrane internaliza-
tion and endocytosis of macromolecules are
complex processes regulated by many pro-
teins associated with GTP and other intracel-
lular messengers (17,18). The handling of
low molecular weight glycoproteins depends
on the amount and type of exposed sugar
residues. Many investigators have shown
that sugar residues interfere with the pattern
of tubular reabsorption (19) or liver uptake.
Liver sinusoidal cells play an important role
in host defense by clearing particulate matter
and macromolecules from the circulation
(20). Yoshioka et al. (21) studied receptor-
mediated endocytosis of chemically modi-
fied glycoproteins by sinusoidal endothelial
cells and Kupffer cells in the liver. Hepatic
cells have specific receptors for asialoglyco-
proteins (22). Endocytosis of plasminogen-
activating factor is mediated by mannose
receptors on endothelial cells rather than
galactose receptors on parenchymal cells (23).
While studying the uptake of Bence Jones
proteins by kidney cells, using immunocy-
tochemistry and electron microscopy (24),
we developed a protocol to study tissue dis-
tribution of Bence Jones proteins in intact
animals, using noninvasive techniques. Scin-
tigraphic analysis permits the continuous
evaluation of renal and hepatic dynamics
and the precise measurement of several func-
tional parameters, thus providing more de-
tailed information. Native Bence Jones pro-
teins were labelled with technetium-99m
(99mTc) and also after treatment with perio-
date. In recent years much effort has been
invested in developing radiolabelled mono-
clonal antibodies for diagnostic and thera-
peutic applications. Because of its excellent
physical characteristics, 99mTc has been used
in diagnostic imaging within a few hours of
administration. No studies correlating the
participation of sugar residues of 99mTc-la-
belled glycoproteins in liver and hepatic dis-
tribution are available. The present study
was carried out in order to obtain more infor-
mation on the pathogenesis of nephrotoxic-
ity.
Material and Methods
Purification of Bence Jones proteins
Human Bence Jones proteins (light chains
of monoclonal immunoglobulins) were ob-
tained from 2 patients with multiple my-
eloma from the Nephrology Division, Uni-
versity of São Paulo School of Medicine,
and purified individually. Urine was con-
centrated through a hollow fiber dialysis
membrane and Tamm-Horsfall proteins were
precipitated with 5% NaCl. Supernatant pro-
teins were precipitated with 70% (NH4)2SO4.
The precipitate was chromatographed on
DEAE-Sephacel in 5 mM sodium phosphate
867
Braz J Med Biol Res 30(7) 1997
Sugar composition and tissue distribution of Bence Jones proteins
buffer, pH 8.0. Both Bence Jones proteins
were submitted to SDS-PAGE for molecular
weight determination, immunoblotting, and
characterization of band specificity (25). The
light chain isotype was determined by im-
munoelectrophoresis (26).
Carbohydrate composition of Bence Jones
proteins
Sialic acid residues were determined as
described by Svennerholm (27), without pre-
vious hydrolysis. The equation proposed by
Spiro (28) was applied to correct for interfer-
ence from neutral hexoses.
Neutral and basic sugar residues were
determined after acid hydrolysis with 4 N
HCl for 4 h at 100oC. The samples were
submitted to ion-exchange chromatography
on mix-bed type resin. Neutral fractions were
eluted in water, resuspended and concen-
trated to dryness. The samples were resus-
pended again and submitted to descending
chromatography on Whatman paper number
one (Whatman Int. Ltd., Maidstone, Eng-
land) for 20 h using two organic solvents:
ethylacetate/isopropanol/water (5:2:1, v/v/
v) and 1.25 N ammonium butyrate. Sugar
residues were detected with silver reagents
in alkaline medium (29) and quantified by
densitometry (Shimadzu CS-9000). Ion-ex-
change chromatography was omitted when
basic residues were determined.
Periodate oxidation of carbohydrate content
of Bence Jones proteins
Carbohydrate oxidation was performed
according to the method of Spiro (30). Both
proteins were treated with 60 mM sodium
metaperiodate in 50 mM sodium acetate
buffer, pH 4.5, at 4oC for 48 h in the dark.
The reaction was monitored by spectropho-
tometry at 225.5 nm (31) and interrupted by
the addition of glucose (0.1 M). Samples
were submitted to SDS-PAGE in order to
determine if large modifications of molecu-
lar weight had occurred as the result of oxi-
dation.
Labelling of Bence Jones proteins with 99mTc
Native and oxidized Bence Jones pro-
teins were labelled with 99mTc by a direct
method (32,33). 99mTc generator was ob-
tained from the Energetic and Nuclear Re-
search Institute (National Council of Nuclear
Engineering, São Paulo). Briefly, 150 mg
stannous chloride (SnCl2) was dissolved in 5
ml of 0.1 N HCl. Fifty µl of this solution was
added to a solution of 30 mg/ml of each
protein, the pH was adjusted to 5.0 and
volume was completed to 3 ml with saline.
The solution was bubbled with nitrogen.
Labelling of 1 mg of oxidized or native
protein with reduced sodium pertechnetate
(99mTc) was allowed to proceed for 15 min.
Radiochemical purity was determined by pa-
per chromatography on Whatman number 3 in
two solvents, i.e., acetone and 0.9% NaCl.
Experimental protocol
99mTc-labelled Bence Jones proteins were
injected iv into male Wistar rats, weighing
approximately 250 g. One mg of native and
oxidized Bence Jones proteins, with 7.4 MBq
activity, was administered to 20 rats (5 rats
per protein). A scintigraphic study was per-
formed for 60 min after administration, and
after 24 h a last recording of tissue distribu-
tion was obtained. A Siemens gamma cam-
era with a high-resolution parallel collimator
was used and data were processed with a
MicroDelta System. Images (128 x 128 ma-
trix) were obtained at 30-s intervals for the
first 5 min and then at 5-min intervals for the
next 55 min after injection of the labelled
protein. Curves for activity vs time were
obtained for organs of interest.
Statistical analysis
Quantitative results were processed by
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the SIGMA PLOT 5.0 software (Sigma stat
Statistical Analysis system version 1.01, Sci-
entific graph system, Jandel Scientific, San
Raphael, CA). Data are reported as median
and 25-75% percentiles. Non-parametric tests
were performed. Rank analysis of variance
was performed by the Kruskal-Wallis test.
Dunn’s test was applied for multiple com-
parison among groups, two by two, when a
significant difference was observed. The
Mann-Whitney test was used for compari-
son between two groups. The level of signif-
icance was set at 0.05.
Results
The Bence Jones proteins were identified
as lambda light chains on the basis of immu-
noelectrophoresis. The molecular weights
determined by SDS-PAGE (Figure 1) were
approximately 28,000.
Sugar analysis was performed by descend-
ing paper chromatography after acid hydroly-
sis. Quantitative data reported as µg/mg pro-
tein are shown in Table 1. The Bence Jones
proteins were named BJg and BJs on the
basis of their galactose and sialic acid con-
tent. BJg presented larger amounts of galac-
tose in comparison to BJs (28.8 vs 4.6 µg/mg
protein). BJs presented higher levels of sialic
acid (4.8 vs 0.3 µg/mg) and mannose (1.0 vs
0.2 µg/mg) compared to BJg. The oligosac-
charides of these Bence Jones proteins were
N-linked while O-linked oligosaccharides
were not detected. BJg presented a larger
amount of carbohydrates than BJs (37.8 vs
12.6 µg/mg) and BJg had a higher percent-
age of basic and neutral sugars in relation to
acid residues (99.2:0.8 vs 61.9:38.1).
The radiochemical purity of Bence Jones
proteins labelled with 99mTc was approxi-
mately 99.9% as determined by paper chro-
matography. A representative diagram of
99mTc decay obtained after infusion of the
radiochemical is shown in Figure 2. The
tissue distribution of native and periodate-
treated proteins is reported as percent of
injected dose (Tables 2 and 3).
BJg uptake by the liver was significantly
higher than BJs uptake (94.3 vs 81.4%)
(P<0.05), contributing to a marked BJg re-
moval from the intravascular compartment.
Consequently, less BJg was taken up by the
kidney in relation to BJs (5.7 vs 18.6%)
(P<0.05).
After periodate treatment of both Bence
Jones proteins there was a significant differ-
ence in the tissue distribution of each protein
(P<0.05). There was a reduction in hepatic
uptake with a consequent increase in renal
distribution of both proteins. Quantitative data
showed that there was a decrease in hepatic
distribution between native and oxidized BJg
(94.3 vs 82.7), and an increase in renal distri-
bution (5.7 vs 17.3%). The same pattern of
hepatic (81.4 vs 71.6%) and renal distribution
(18.6 vs 28.4%) was observed with BJs before
and after sugar oxidation, respectively. Oxi-
dized BJg presented a similar hepatic distribu-
tion (82.7 vs 81.4%) and consequently a simi-
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Figure 1 - Determination of the molecular mass of BJg and
BJs by SDS-PAGE. S, Molecular mass standards.
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lar renal distribution (17.3 vs 18.6%) of native
BJs under these conditions.
Discussion
Many clinical manifestations occur in
patients with multiple myeloma, with vari-
ous degrees of kidney involvement. Some
cases are characterized by massive proteinu-
ria and normal renal function, and others by
severe renal lesions not related to proteinu-
ria (34). The origin of these differences could
be related to systemic characteristics of the
patients (35) as well as the physicochemical
properties of Bence Jones proteins (11).
The role of carbohydrate content of Bence
Jones proteins has not been extensively stud-
ied. Monoclonal immunoglobulin light chains
are highly glycosylated (13,36). The molar
ratio between basic and neutral sugars vs
acid residues is not constant in myeloma
immunoglobulins (37,38), whereas this ratio
is approximately 76:24 for normal immuno-
globulins (39). In spite of advances in the
analysis of glycoprotein-associated oligosac-
charides (40), there are no reports in the
literature about the relationship of tissue
distribution to exposed carbohydrate resi-
dues.
The present results show that the rela-
tionship between basic and neutral sugars vs
acid residues of BJs studied here is similar to
the ratio found in normal immunoglobulins.
Differences in the carbohydrate composi-
tion between BJ proteins have been observed
by several laboratories and a straight corre-
lation with possible pathogenesis has been
suggested (41).
In our study, the galactose-rich BJ pro-
tein suffered intense endocytosis by asialo-
glycoreceptors, both at the hepatic and renal
level. Interestingly, the patient who produced
this protein developed severe kidney disease
and had renal insufficiency resulting in death.
In addition, the sialic acid-rich BJ protein
obtained from another patient presented a
smaller amount of galactose residues in com-
Table 1 - Carbohydrate composition of the two
Bence Jones proteins used in the present study.
Data are reported as µg carbohydrate/mg protein.
Carbohydrate BJg BJs
Total 37.8 12.6
Neutral
Galactose 28.8 4.6
Mannose 0.2 1.0
Fucose 0.2 0.5
Basic
Glucosamine 8.3 1.7
Acidic
Sialic acid 0.3 4.8
%
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Figure 2 - Liver and renal up-
take of Bence Jones proteins
as native proteins (BJg and
BJs) and after metaperiodate
oxidation (BJgm and BJsm).
BJg: Bence Jones protein rich
in galactose; BJs: Bence
Jones protein rich in sialic
acid. n.s., Not significant.
Table 2 - Hepatic distribution of Bence Jones pro-
teins before (BJg, BJs) and after metaperiodate
oxidation (BJgm, BJsm).
Data are reported as median (25-75% percentiles).
Kruskal-Wallis method: P<0.001. Dunn’s test: BJg
vs BJs, BJg vs BJgm, BJgm vs BJsm and BJs vs
BJsm: *P<0.05. Five animals in each group.
Protein % of injected dose
BJg 94.3 (92.8-95.6)
BJgm 82.7 (78.0-88.4)
BJs 81.4 (79.5-83.2)
BJsm 71.6 (69.5-77.3)
*
*
*
*
parison to BJg. Clinical intervention led to a
successful treatment, with survival without
renal failure in the follow-up. Covering of
galactose residues by sialic acid residues
could be the mechanism implied in mild
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pathogenicity, causing a reduced uptake of
this protein either by liver or kidney cells.
Two different factors should be considered,
i.e., tissue distribution and uptake. We found
a marked distribution of BJg protein at the
hepatic level, presumably related to galac-
tose residues and recognition by specific
receptors for asialoglycoproteins and conse-
quently a reduced renal uptake (see Ref. 22
for a review). At the hepatic level there was
a positive correlation between distribution
and tissue uptake, while at the renal level the
distribution was complementary. On the ba-
sis of the total amount in the kidney, it
appears that renal uptake and catabolism of
Bence Jones proteins is mainly the result of
an efficient endocytic apparatus of proximal
tubular cells. Pathogenicity may be directly
related to the recognition by specific recep-
tors, providing an efficient internalization
by liver and kidney cells and consequently
intracellular effects. In our experiments, car-
bohydrate oxidation was associated with a
significant reduction of liver uptake of both
proteins. Increased kidney uptake was prob-
ably a result of decreased hepatic accumula-
tion. At the renal level we cannot assume
that increased protein load shown by scinti-
graphy is associated with increased tissue
uptake because low molecular weight pro-
teins can be cleared by urinary excretion. An
important role of carbohydrate residues in
the interaction of BJ proteins with Tamm-
Horsfall proteins has been previously shown
(42), and this favors kidney obstruction.
These authors observed that cast formation
and tubular obstruction were associated with
sialic acid residues of Tamm-Horsfall pro-
teins secreted in the tubular lumen by Henle
loop cells. Colchicine treatment prevented
cast formation by modifying the biosynthe-
sis of Tamm-Horsfall proteins secreted with-
out sialic acid under these conditions.
Furthermore, mannose residues also seem
to play an important role in endocytosis since
we observed a significant reduction in he-
patic distribution and uptake after deglyco-
sylation. Mannose recognition was probably
mediated by specific receptors in hepatic
and kidney cells as shown previously by
other investigators who observed that the
endocytosis of plasminogen-activating fac-
tor was mediated by mannose receptors on
liver endothelium and by galactose receptors
on parenchymal cells (23). Plasminogen-ac-
tivating factor endocytosis was shown to be
greater in endothelial cells (43), but it was
practically absent in Kupffer cells. In a study
using mannose covalently attached to albu-
min, a positive correlation between density
of mannose residues of albumin and en-
docytic rate by non-parenchymal liver cells
was demonstrated (44). Many investigators
have studied the role of carbohydrate com-
position in liver cell endocytosis and ob-
served that similar effects induced by degly-
cosylation could be obtained by removal of
galactose residues.
In conclusion, we demonstrated a corre-
lation between the carbohydrate content of
Bence Jones proteins and their tissue distri-
bution in a scintigraphic study. This proce-
dure may be useful for other radiochemicals
and could contribute to the elucidation of the
mechanism of other diseases. Indeed, label-
ling with 99mTc provided high accuracy and
efficiency and permitted noninvasive dynam-
ic studies.
Table 3 - Renal distribution of Bence Jones pro-
teins before (BJg, BJs) and after metaperiodate
oxidation (BJgm, BJsm).
Data are reported as median (25-75% percentiles).
Kruskal-Wallis method: P<0.001. Dunn’s test: BJg
vs BJs, BJg vs BJgm, BJgm vs BJsm and BJs vs
BJsm: *P<0.05. Five animals in each group.
Protein % of injected dose
BJg 5.7 (4.4-7.3)
BJgm 17.3 (11.6-24.7)
BJs 18.6 (16.8-20.5)
BJsm 28.4 (22.8-30.6)
*
*
*
*
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